A SECRET WEAPON FOR AGO TUMOR

Set up immune markers continue to preserve their relevance for clinical determination-producing in breast cancer remedy with even prolonged meanings. Estrogen receptor (ER) level must not only be categorized in constructive or adverse. Low ER stages ≤10% of labeled cells ought to be handled in another way (LoE 1a/A/AGO++). Tumors with low ER leve